Bringing a Leukemic Stem Cell Gene Signature into Clinics: Are We There Yet?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28257710.
- Also identified by DOI 10.1016/j.stem.2017.02.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prognostic markers that capture leukemia stem cell (LSC) activity can be useful for the risk stratification of acute myeloid leukemia (AML) patients. In a recent issue of Nature, Ng et al. (2016) develop a prognostic score based on a 17-gene expression signature of LSCs to predict outcome in AML patients.
Medical subject headings
- Leukemia, Myeloid, Acute
- Neoplastic Stem Cells